News
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
Trump appeared to acknowledge in the interview that his ruthless mass deportation campaign is hurting farms, which rely on ...
7h
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own MedicineAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
13hOpinion
The New Republic on MSNGhislaine Maxwell Claims Trump Approved Request on Epstein TranscriptsJeffrey Epstein’s convicted accomplice revealed something interesting about her communication with the Trump administration.
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
21h
AlterNet on MSN'Hidden hand': MAGA Republicans slam Laura Loomer as a Big Pharma 'plant'Bulwark reporter Will Sommer reports MAGA influencer Laura Loomer is drawing criticism from MAGA members who claim she’s ...
15h
The New Republic on MSNLaura Loomer’s New Influence Is Already Backfiring on HerLaura Loomer’s conspiratorial followers are already cannibalizing her for participating in “the swamp.” Just a day after reports emerged that Defense Secretary Pete Hegseth had tapped the far-right “9 ...
Detailed price information for Cf Industries Holdings (CF-N) from The Globe and Mail including charting and trades.
The US Food and Drug Administration’s (FDA) top vaccine official is stepping down after just three months in a role that upset drug companies, patient groups and some political leaders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results